New hope for rare cancers: drug combo shows promise in shrinking tumors
NCT ID NCT01396408
First seen Apr 20, 2026 · Last updated Jun 17, 2026 · Updated 16 times
Summary
This study tests two drugs, sunitinib and temsirolimus, in 137 people with advanced rare cancers that have no cure. The goal is to see if these drugs can shrink tumors or slow their growth. While not a cure, the approach aims to better control the disease and improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1, Canada
-
BCCA - Cancer Centre for the Southern Interior
Kelowna, British Columbia, V1Y 5L3, Canada
-
BCCA - Vancouver Cancer Centre
Vancouver, British Columbia, V5Z 4E6, Canada
-
CHU Sainte-Justine
Montreal, Quebec, H3T 1C5, Canada
-
CHUM - Hopital Notre-Dame
Montreal, Quebec, H2L 4M1, Canada
-
CancerCare Manitoba
Winnipeg, Manitoba, R3E 0V9, Canada
-
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
-
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
-
Izaak Walton Killam (IWK) Health Centre
Halifax, Nova Scotia, B3K 6R8, Canada
-
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, L8V 5C2, Canada
-
London Regional Cancer Program
London, Ontario, N6A 4L6, Canada
-
McGill University - Dept. Oncology
Montreal, Quebec, H2W 1S6, Canada
-
Ottawa Hospital Research Institute
Ottawa, Ontario, K1H 8L6, Canada
-
QEII Health Sciences Centre
Halifax, Nova Scotia, B3H 1V7, Canada
-
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4, Canada
-
Tom Baker Cancer Centre
Calgary, Alberta, T2N 4N2, Canada
-
Univ. Health Network-Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.